WednesdayOct 21, 2026 3:47 pm

QualityStocksNewsBreaks – AZIO AI Holdings Inc. (NASDAQ: AZIO) Launches Atlas One to Address Growing AI Power Demand

AZIO AI Holdings (NASDAQ: AZIO) has unveiled Atlas One, a South Texas data center campus designed to address growing AI computing demand by developing dedicated, on-site power infrastructure. Spanning more than 548 acres, the project is engineered for up to 500 megawatts of planned behind-the-meter power capacity, with approximately 11 megawatts of natural gas generation and supporting electrical infrastructure already secured and about 6 megawatts activated for an initial Bitcoin mining workload. The company has also committed approximately $2.4 million to an AT&T agreement for dedicated enterprise fiber connectivity. Atlas One is intended to connect Azio AI’s GPU hardware business…

Continue Reading

WednesdayOct 21, 2026 3:21 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Expands Overwatch Strategy Across Drone Manufacturers, Government Markets

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is developing a network-based approach to GPS-denied positioning through its Overwatch Positioning Network, a service designed to provide drone location data when satellite navigation is jammed, spoofed or unavailable. Launched in August 2026, Overwatch processes existing aircraft telemetry in secure data centers and returns latitude, longitude and time in approximately one-third of a second, without requiring additional onboard hardware or software. The company aims to make the technology scalable across large drone fleets by shifting computational requirements from…

Continue Reading

WednesdayOct 21, 2026 2:55 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Aims for Greater Precision in Cancer Therapy

VERAXA Biotech (NASDAQ: VRXA) is developing antibody-based cancer therapies designed to improve treatment selectivity and potentially reduce toxicity to healthy tissues. At the center of its strategy is the proprietary BiTAC (Bi-targeted Tumor-Associated Cytotoxicity) platform, which uses two complementary molecules designed to activate cancer-killing activity only when both recognize targets on the same tumor cell. The company is applying this approach to antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with a particular focus on solid tumors. VERAXA reported promising preclinical findings for its lead BiTAC-TCE program, including selective targeting of cells expressing both intended targets and improved safety alongside comparable…

Continue Reading

TuesdayOct 20, 2026 3:43 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Unveils SSi Mantra 3.0 at Kings Hospital Colombo

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, is expanding its international footprint with the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo, powered by its SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva, and the hospital reportedly completed more than 25 robotic procedures within the first three weeks. The launch adds to SS Innovations’ international expansion as the company reported 224 cumulative SSi Mantra installations…

Continue Reading

TuesdayOct 20, 2026 3:14 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Scales GelrinC Manufacturing Amidst Development Progress

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel technology, designed to promote the regeneration of durable, natural-like cartilage in patients with painful knee cartilage injuries. The cell-free, off-the-shelf implant temporarily fills cartilage defects before gradually resorbing as surrounding tissue regenerates. Long-term MRI findings and peer-reviewed Phase II clinical data have provided evidence of cartilage maturation and durable structural repair, while the company has reported greater pain improvement than traditional microfracture. Regentis has treated 43 of 80 planned patients in its U.S. pivotal Phase III trial, with enrollment expected to conclude around the end of 2026, and is preparing for…

Continue Reading

FridayOct 16, 2026 3:54 pm

QualityStocksNewsBreaks – Numa Numa Resources Inc. Builds Multiproject Strategy Around Bougainville’s Mineral Resources

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources is advancing a multiproject development strategy in Bougainville, Papua New Guinea, with its flagship Panguna copper-gold mine redevelopment positioned to benefit from rising metals prices and growing global demand for critical resources. Historically operated by Rio Tinto from 1972 to 1989, Panguna produced approximately 3 million tonnes of copper and 9.3 million ounces of gold before operations ceased amid landowner grievances and civil conflict. The company cites historical reserve estimates of 5.3 million metric tons of copper and 547.15 metric tons of gold, while…

Continue Reading

FridayOct 16, 2026 3:40 pm

QualityStocksNewsBreaks – Nano-X Imaging Ltd. (NASDAQ: NNOX) Highlights Insider Buying Alongside Its Integrated Healthcare Technology Strategy

Recent SEC Form 4 filings disclosed open-market purchases of Nano-X Imaging Ltd.’s (NASDAQ: NNOX) (“Nanox”) ordinary shares by CEO Erez Meltzer and Board Director Dan Suesskind, adding to purchases reported in recent months by Meltzer, Suesskind and Board Director Nogah Keinan. The transactions reflect share purchases made directly in the open market by the company’s senior leadership and board members, with additional details available in the respective SEC filings. This comes as Nanox continues to advance its integrated medical imaging and healthcare services platform, which combines proprietary digital X-ray technology, AI-powered imaging analytics, cloud-based software, remote radiology services and healthcare…

Continue Reading

FridayOct 16, 2026 3:14 pm

QualityStocksNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) Partners with Canadian Consortium on AI-Driven Cancer Research

Disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) has joined a Canadian oncology research consortium as a co-applicant in a competitive Terry Fox Research Institute grant supporting the development of Onco-Innovations’ SynoGraph(TM) artificial intelligence platform. The research project will investigate whether causal AI, combined with preclinical research and real-world clinical, genomic and imaging data, can improve predictions of how investigational therapies may perform in human trials. Redwood AI will contribute proprietary data integration, feature engineering and physicochemical modelling methods, working alongside Onco-Innovations and academic research partners that will supply clinical and genomic…

Continue Reading

FridayOct 16, 2026 2:39 pm

QualityStocksNewsBreaks – Silynxcom Ltd. (NYSE American: SYNX) Expands European Defense Presence with New CLARUS Orders

Silynxcom (NYSE American: SYNX) has received two consecutive purchase orders totaling approximately $400,000 from a leading global defense company for its CLARUS In-Ear Headset product family, with the systems designated for a European army. The modular CLARUS platform combines hearing protection, tactical communications, an in-ear microphone and situational awareness features, including drone detection. According to CEO Nir Klein, the orders reflect the company’s established relationship with a major defense customer and continued recognition of its products among European military organizations. The purchases also support Silynxcom’s efforts to expand its presence in European defense markets as military and security customers seek…

Continue Reading

FridayOct 16, 2026 1:55 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Advances Training Framework for Remote Restraint, De-Escalation

Wrap Technologies (NASDAQ: WRAP) has developed a new operational doctrine designed to help law enforcement officers manage encounters when verbal de-escalation alone does not resolve a situation. The framework combines communication, recognition of resistance, tactical positioning, time and distance, and remote restraint using the company’s BolaWrap 150 device, which deploys a tether intended to restrain a person without electrical incapacitation or chemical irritants. The approach is designed to give officers an additional option in certain encounters, including behavioral and mental health emergencies, while emphasizing the use of the lowest reasonable level of response and continuous reassessment as circumstances change. Following…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered